Anti-Human LRRN1 Recombinant Antibody (TB0777#281-6 (N1mAb))

CAT#: TAB-522MZ

This antibody recognizes human LRRN1 (Leucine-rich-repeat-neuronal protein-1), also called NLRR1 (Neuronal leucine-rich repeat protein 1). This antibody binds to the Ig domain and fibronectin type III domain of LRRN1 as measured by flow cytometry. The antibody showed a cell growth inhibitory effect.

Published Data Gene Expression
Figure 1 A is a SY5Y-ctrl, B is a result of SY5Y-N1. Figure 2 It shows that the treatment with N1mAb antibody (# 281-6) was significantly inhibited the growth of xenograft tumors. Figure 3 It shows that the treatment with N1mAb antibody (# 281-6) was significantly inhibited the growth of xenograft tumors.
Figure 1 IHC staining of human cerebral cortex Figure 2 IHC staining of human lymph node Figure 3 Colon Figure 4 Liver Figure 5 Kidney Figure 6 Testis Figure 7 RNA cell line category: Cell line enhanced (AF22, CAPAN-2, HAP1, NTERA-2, SuSa)

Specifications

  • Host Species
  • Mouse
  • Specificity
  • Human
  • Clone
  • TB0777 # 281-6 (N1mAb)
  • Applications
  • ELISA, FC, Inhib, FuncS
  • Related Disease
  • Cancers including neuroblastoma, pulmonary cancer, mammary cancer

Applications

  • Application Notes
  • The antibody was validated for Inhibition and Function assay. For details, refer to Published Data.

Target

  • Alternative Names
  • NLRR-1; FIGLER3
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for TAB-522MZ. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression David Evans
10.Sep,23
Excellent for LRRN1 Research
The Anti-LRRN1 Therapeutic Antibody has been excellent for our LRRN1 studies. Its specificity and sensitivity are top-notch, providing clear and reliable results. This antibody has significantly improved the accuracy of our experiments and saved us a lot of troubleshooting time.
Breast cancer biomarkers at key points during disease progression Laura Baker
08.Nov,22
Effective in Immunoassays
We incorporated this antibody into our immunoassays, and it has been a great asset. The specificity for LRRN1 is precise, allowing for accurate detection and analysis. The reliable performance has made it an invaluable tool in our lab.
Breast cancer biomarkers at key points during disease progression Jessica Turner
03.Aug,21
Consistent and High-Quality
This antibody has proven to be consistent and high-quality in our various assays. The reproducible results and strong affinity for LRRN1 have significantly improved our experiments, making it a crucial part of our research toolkit. The consistent performance has greatly enhanced our data quality.

Q&As

  1. Is the anti-LRRN1 therapeutic antibody suitable for flow cytometry analysis?

    A: Yes, the anti-LRRN1 therapeutic antibody (TAB-522MZ) is suitable for flow cytometry analysis. It is designed to specifically bind to LRRN1, making it suitable for detecting LRRN1-expressing cells in flow cytometry.

  2. What are the recommended storage conditions for the anti-LRRN1 therapeutic antibody?

    A: The recommended storage condition for the anti-LRRN1 therapeutic antibody (TAB-522MZ) is at -20°C or lower. For short-term storage, it can be kept at 2-8°C. To ensure stability, avoid repeated freeze-thaw cycles.

  3. Can the anti-LRRN1 therapeutic antibody be used in immunoprecipitation assays?

    A: Yes, the anti-LRRN1 therapeutic antibody (TAB-522MZ) can be used in immunoprecipitation assays. It provides specific binding to LRRN1, enabling the successful precipitation of the target protein from complex mixtures.

  4. Is the anti-LRRN1 therapeutic antibody effective in ELISA applications?

    A: Yes, the anti-LRRN1 therapeutic antibody (TAB-522MZ) is effective in ELISA applications. It has been validated for use in such assays and provides reliable detection of LRRN1.

  5. What is the optimal dilution for using the anti-LRRN1 therapeutic antibody in Western blotting?

    A: The optimal dilution for using the anti-LRRN1 therapeutic antibody (TAB-522MZ) in Western blotting is typically 1:500 to 1:2000. It is advisable to perform a dilution series to determine the best working concentration for your specific experimental conditions.

View the frequently asked questions answered by Creative Biolabs Support.

Citations

  1. Wei, Yun, et al. "Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcoma." Nature cancer 3.8 (2022): 961-975. https://doi.org/s43018-022-00414-w
    This study investigates the conservation of cellular hierarchy and the identification of tumor-propagating cells (TPCs) in rhabdomyosarcoma (RMS) using single-cell RNA sequencing, DNA-barcode cell fate mapping, and functional stem cell assays. The research uncovers shared tumor cell hierarchies in RMS and human muscle development, identifying common developmental stages where tumor cells become arrested. It highlights the molecularly-defined TPCs in fusion-negative RMS (FN-RMS) that resemble early myogenic cells found in embryonic and fetal development. These TPCs are quiescent under normal conditions but can re-enter the cell cycle to drive tumor growth under stress or in vivo conditions.
    Creative Biolabs provided crucial reagents for this study, specifically the anti-LRRN1 antibody (Cat# TAB-522MZ). These antibodies were essential for the fluorescence-activated cell sorting (FACS) used to isolate mesenchymal-like and differentiated muscle cell populations. By enabling the identification and enrichment of specific cell states within FN-RMS, these reagents facilitated the detailed characterization of TPCs and their role in tumor growth and maintenance, supporting the study's exploration of cellular hierarchies in RMS.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# TAB-522MZ, RRID: AB_3111968)

Copy citation

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "Clone TB0777 # 281-6 (N1mAb)"

See other products for "LRRN1"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
FAMAB-0617WJ Mouse Anti-LRRN1 Recombinant Antibody (clone 2.5.1) ELISA, WB Mouse IgG
CAT Product Name Application Type
VS-0425-YC126 Recombinant Anti-LRRN1 Vesicular Antibody, EV Displayed (VS-0425-YC126) ELISA, FC, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare